CEREBYX Side Effects

6787455-2 | Extravasation
on Apr 24, 2007 Female patient from UNITED STATES , weighting 205.0 lb, was diagnosed with convulsion prophylaxis and was treated with Cerebyx (View Usage). Patient experienced the following unwanted or unexpected effects: extravasation. Cerebyx dosage: .

5735538-8 | Incorrect Dose Administered
Patient was taking Cerebyx (View Usage). Patient had the following side effects: incorrect dose administered on Apr 30, 2008 from UNITED STATES Additional patient health information: Male patient , child 3 years of age, . Cerebyx dosage: Daily Dose:2000mg.

5715583-9 | Erythema, Pruritus, Rash
Adverse event was reported on Apr 23, 2008 by a Female patient taking Cerebyx (View Usage) (Dosage: 1 Gm X 1 Iv) . Location: UNITED STATES , 48 years of age, After Cerebyx was administered, patient had the following side effects: erythema, pruritus, rash (What is rash?).

5698106-2 | Incorrect Dose Administered
on Mar 27, 2008 Male patient from UNITED STATES , child 3 years of age, was treated with Cerebyx (View Usage). Patient experienced the following unwanted or unexpected effects: incorrect dose administered. Cerebyx dosage: Daily Dose:2000mg.


5679082-5 | Incorrect Dose Administered
on Mar 24, 2008 Male patient from UNITED STATES , child 3 years of age, was treated with Cerebyx (View Usage). Patient had the following side effects: incorrect dose administered. Cerebyx dosage: Injectable.

5660991-8 | Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Dyskinesia, White Blood Cell Count Increased
Patient was taking Cerebyx (View Usage). After Cerebyx was administered, patient had the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, dyskinesia, white blood cell count increased on Feb 25, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 158.7 lb, was diagnosed with grand mal convulsion and. Cerebyx dosage: . During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), NAMENDA (View Namenda Review and Namenda Label ).

5596381-6 | Aggression, Agitation, Encephalitis
Adverse event was reported on Jan 09, 2008 by a Male patient taking Cerebyx (View Usage) (Dosage: Daily Dose:900mg) was diagnosed with grand mal convulsion and. Location: UNITED STATES , weighting 126.3 lb, Patient experienced the following unwanted or unexpected effects: aggression, agitation, encephalitis (What is encephalitis?). During the same period patient was treated with DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NORVASC (View Norvasc Review and Norvasc Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), PLAVIX (View Plavix Review and Plavix Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), UNIVASC (View Univasc Review and Univasc Label ). Patient was hospitalized.

5486070-0 | Angioedema, Pulmonary Oedema, Respiratory Failure, Skin Reaction
on Oct 03, 2007 Female patient from UNITED STATES , child 7 years of age, was diagnosed with convulsion and was treated with Cerebyx (View Usage). Patient had the following side effects: angioedema, pulmonary oedema, respiratory failure, skin reaction. Cerebyx dosage: .

5484058-7 | Blister, Convulsion, Incoherent, Open Wound, Skin Discolouration, Skin Exfoliation, Subarachnoid Haemorrhage, Subdural Haematoma
on Oct 09, 2007 Male patient from UNITED STATES , 72 years of age, was treated with Cerebyx (View Usage). After Cerebyx was administered, patient had the following side effects: blister, convulsion, incoherent, open wound, skin discolouration, skin exfoliation, subarachnoid haemorrhage, subdural haematoma. Cerebyx dosage: . Patient was hospitalized.

5421904-7 | Incorrect Dose Administered, Overdose
Patient was taking Cerebyx (View Usage). Patient experienced the following unwanted or unexpected effects: incorrect dose administered, overdose on Aug 20, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 26.46 lb, was diagnosed with convulsion and. Cerebyx dosage: 2000 Mg Once Iv. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ).

5406600-4 | Purple Glove Syndrome
Adverse event was reported on Jul 25, 2007 by a Male patient taking Cerebyx (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 200.4 lb, Patient had the following side effects: purple glove syndrome.

5351972-2 | Injection Site Reaction
on Nov 03, 2006 Female patient from UNITED STATES , child 5 years of age, was treated with Cerebyx (View Usage). After Cerebyx was administered, patient had the following side effects: injection site reaction. Cerebyx dosage: .

5315114-1 | Diabetes Insipidus, Hypernatraemia
on Apr 19, 2007 Female patient from UNITED STATES , weighting 95.90 lb, was diagnosed with grand mal convulsion, enuresis and was treated with Cerebyx (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes insipidus (What is diabetes insipidus?), hypernatraemia. Cerebyx dosage: . During the same period patient was treated with DDAVP (NEEDS NO REFRIGERATION) (View Ddavp (needs No Refrigeration) Review and Ddavp (needs No Refrigeration) Label ).

5265910-4 | Bradycardia, Cardiac Arrest, Hypotension
Patient was taking Cerebyx (View Usage). Patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?), hypotension on Mar 12, 2007 from UNITED STATES Additional patient health information: Female patient , 91 years of age, was diagnosed with convulsion and. Cerebyx dosage: 1 Gm Iv X 1 Dose.

5255680-8 | Arthropod Bite, Coagulopathy, Formication, Pruritus, Red Blood Cell Count Decreased, Renal Function Test Abnormal, White Blood Cell Count Increased
Adverse event was reported on Feb 21, 2007 by a Female patient taking Cerebyx (View Usage) (Dosage: ) was diagnosed with convulsion and. Location: UNITED STATES , weighting 251.1 lb, After Cerebyx was administered, patient had the following side effects: arthropod bite, coagulopathy, formication, pruritus, red blood cell count decreased, renal function test abnormal, white blood cell count increased. During the same period patient was treated with ALBUTEROL SULFATE/IPRATROPIUM BROMIDE (View Albuterol Sulfate/ipratropium Bromide Review and Albuterol Sulfate/ipratropium Bromide Label ), REGULAR INSULIN (View Regular Insulin Review and Regular Insulin Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), LASIX (View Lasix Review and Lasix Label ), METHYLPREDNISOLONE ACETATE (View Methylprednisolone Acetate Review and Methylprednisolone Acetate Label ).

5253547-2 | Diabetes Insipidus, Hypernatraemia
on Feb 19, 2007 Female patient from UNITED STATES , weighting 95.90 lb, was diagnosed with grand mal convulsion, enuresis and was treated with Cerebyx (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes insipidus (What is diabetes insipidus?), hypernatraemia. Cerebyx dosage: . During the same period patient was treated with DDAVP (NEEDS NO REFRIGERATION) (View Ddavp (needs No Refrigeration) Review and Ddavp (needs No Refrigeration) Label ).

5171662-9 | Formication, Pruritus, Red Blood Cell Count Decreased, Renal Function Test Abnormal, Thrombosis, White Blood Cell Count Increased
on Nov 20, 2006 Female patient from UNITED STATES , 58 years of age, weighting 251.0 lb, was treated with Cerebyx (View Usage). Patient had the following side effects: formication, pruritus, red blood cell count decreased, renal function test abnormal, thrombosis, white blood cell count increased. Cerebyx dosage: 1000 Mg, Intravenous. During the same period patient was treated with ALBUTEROL SULFATE/IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE, SALBUTAMOL (View Albuterol Sulfate/ipratropium Bromide (ipratropium Bromide, Salbutamol Review and Albuterol Sulfate/ipratropium Bromide (ipratropium Bromide, Salbutamol Label ), INSULIN, REGULAR (INSULIN) (View Insulin, Regular (insulin) Review and Insulin, Regular (insulin) Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

5162378-3 | Infusion Related Reaction, Pruritus
Patient was taking Cerebyx (View Usage). After Cerebyx was administered, patient had the following side effects: infusion related reaction, pruritus on Nov 27, 2006 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 100.0 lb, was diagnosed with convulsion and. Cerebyx dosage: 100 Mg One Dose Iv Bolus.

5062728-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased
Adverse event was reported on Jul 24, 2006 by a Female patient taking Cerebyx (View Usage) (Dosage: See Image) was diagnosed with atrial fibrillation (What is atrial fibrillation?), cerebrovascular accident, convulsion prophylaxis, diabetes mellitus and. Location: UNITED STATES , weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased. During the same period patient was treated with CARDIZEM (View Cardizem Review and Cardizem Label ).

5032375-7 | Pancytopenia
on Jun 21, 2006 Female patient from UNITED STATES , 27 years of age, weighting 46.08 lb, was diagnosed with convulsion and was treated with Cerebyx (View Usage). Patient had the following side effects: pancytopenia. Cerebyx dosage: 300 Mg Once Iv.

4970141-9 |
on Mar 24, 2006 Male patient from UNITED STATES , 45 years of age, was diagnosed with convulsion and was treated with Cerebyx (View Usage). . Cerebyx dosage: 1500 Mg (1500 Mg, 1 In 1d), Intravenous. During the same period patient was treated with ANTIEPILEPTICS (ANTIEPILEPTICS) (View Antiepileptics (antiepileptics) Review and Antiepileptics (antiepileptics) Label ).

4966977-0 |
Patient was taking Cerebyx (View Usage). on Mar 20, 2006 from UNITED STATES Additional patient health information: Male patient , 45 years of age, was diagnosed with convulsion and. Cerebyx dosage: . During the same period patient was treated with ANTIEPILEPTICS (ANTIEPILEPTICS) (View Antiepileptics (antiepileptics) Review and Antiepileptics (antiepileptics) Label ).

4962819-8 | Hypotension, Rash Erythematous, Respiratory Gas Exchange Disorder, Wheezing
Adverse event was reported on Apr 03, 2006 by a Female patient taking Cerebyx (View Usage) (Dosage: 1000 Mg Once Iv Drip [1 Dose]) was diagnosed with convulsion and. Location: UNITED STATES , 84 years of age, weighting 141.1 lb, Patient had the following side effects: hypotension, rash erythematous, respiratory gas exchange disorder, wheezing. Patient was hospitalized.

4843880-8 | Liver Function Test Abnormal
on Nov 30, 2005 Female patient from UNITED STATES , 74 years of age, weighting 163.1 lb, was diagnosed with convulsion and was treated with Cerebyx (View Usage). After Cerebyx was administered, patient had the following side effects: liver function test abnormal. Cerebyx dosage: 200 Mg Q12h Iv; 100 Mg Q8h Iv. Patient was hospitalized and became disabled.

4732567-8 | Hypotension
on Aug 01, 2005 Female patient from UNITED STATES , 27 years of age, weighting 132.3 lb, was diagnosed with convulsion and was treated with Cerebyx (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension. Cerebyx dosage: 900mg Once Intravenou.

4660304-4 | Screaming, Self Injurious Behaviour, Sensory Disturbance, Verbal Abuse
Patient was taking Cerebyx (View Usage). Patient had the following side effects: screaming, self injurious behaviour, sensory disturbance, verbal abuse on May 11, 2005 from Additional patient health information: Female patient , weighting 10.90 lb, was diagnosed with convulsion and. Cerebyx dosage: .

4591669-X | Laboratory Test Interference, Respiratory Distress
Adverse event was reported on Feb 08, 2005 by a Male patient taking Cerebyx (View Usage) (Dosage: 300 Mg (100 Mg, 3 In 1) was diagnosed with convulsion and. Location: , 57 years of age, After Cerebyx was administered, patient had the following side effects: laboratory test interference, respiratory distress. During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), AZTREONAM (AZTREONAM) (View Aztreonam (aztreonam) Review and Aztreonam (aztreonam) Label ), EPOETIN ALFA (EPOETIN ALFA) (View Epoetin Alfa (epoetin Alfa) Review and Epoetin Alfa (epoetin Alfa) Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMINS (VITAMINS) (View Vitamins (vitamins) Review and Vitamins (vitamins) Label ), INSULIN (View Insulin Review and Insulin Label ).

4574499-4 | Cholecystectomy, Depressed Level Of Consciousness, Gastric Disorder, Gastrointestinal Infection, Gastrointestinal Necrosis, Pneumonia, Pyrexia, Swelling, Tracheostomy
on Jan 21, 2005 Male patient from , 77 years of age, weighting 220.0 lb, was diagnosed with convulsion and was treated with Cerebyx (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystectomy, depressed level of consciousness, gastric disorder, gastrointestinal infection, gastrointestinal necrosis, pneumonia (What is pneumonia?), pyrexia, swelling, tracheostomy. Cerebyx dosage: 600 Mg (200 Mg, 3 In 1 D), Intravenous. During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), PIPERACILLIN (View Piperacillin Review and Piperacillin Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), HEPARIN (View Heparin Review and Heparin Label ).